Rockwell Medical
RMTI
36 hedge funds and large institutions have $2.18M invested in Rockwell Medical in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 25 closing their positions.
656% more call options, than puts
Call options by funds: $121K | Put options by funds: $16K
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
1.93% more ownership
Funds ownership: 0.19% → 2.11% (+1.9%)
38% less funds holding
Funds holding: 58 → 36 (-22)
76% less capital invested
Capital invested by funds: $9.13M → $2.18M (-$6.95M)
88% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 25
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$546K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$102K |
| 3 |
VCA
Verdence Capital Advisors
Hunt Valley,
Maryland
|
+$60.8K |
| 4 |
VF
Virtu Financial
New York
|
+$42.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$35.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$65K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$54K |
| 3 |
RCAG
Rehmann Capital Advisory Group
Lansing,
Michigan
|
-$29K |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$22K |
| 5 |
OFS
OneAscent Financial Services
Birmingham,
Alabama
|
-$19K |
RMTI Hedge Fund Activity: Q2 2022 in Review
36 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Rockwell Medical (RMTI) for Q2 2022, worth a combined $2.18M — down 76% from $9.13M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of RMTI and 3 opened new positions — a net loss of 22 holders — while 8 trimmed existing stakes and 12 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $546K. The largest seller was Millennium Management, cutting an estimated $65K.
- 36 institutional investors held Rockwell Medical (RMTI) as of Q2 2022, down from 58 in Q1 2022.
- Funds reported $2.18M of Rockwell Medical stock for Q2 2022, down 76% quarter-over-quarter.
- 3 funds opened new Rockwell Medical positions in Q2 2022 and 25 closed out, a net change of -22 holders.
- The largest Rockwell Medical buyer in Q2 2022 was Armistice Capital, an estimated $546K added.
- The largest Rockwell Medical seller in Q2 2022 was Millennium Management, an estimated $65K sold.
Based on aggregated 13F filings for Q2 2022.